What Happened?
Malvern, PA-based Endo has Retired Caroline B. Manogue as Chief Legal Officer
About the Company
Endo International plc is a highly focused generics and specialty pharmaceutical company delivering quality medicines through excellence in development, manufacturing and commercialization. Through our operating companies – Endo Pharmaceuticals, Par Pharmaceutical and Paladin Labs – Endo is dedicated to serving patients in need. Endo commenced operations in 1997 by acquiring certain pharmaceutical products, related rights and assets from The DuPont Merck Pharmaceutical Company. Since that time, the company has expanded to include the following business segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals and International Pharmaceuticals. Endo`s strategy is to centralize and unify our business, driving productivity improvements. We will focus on organic growth by investing in hard-to-produce generic assets & technologies and transforming the branded business into a highly focused Specialty business. Additionally, we are concentrating on differentiated and intelligent product selection to shape our company for long-term success. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, Pennsylvania. We employ approximately 3,400 people worldwide*.
About the Person
Caroline B. Manogue has served as Executive Vice President, Chief Legal Officer since 2004. She also served as Corporate Secretary and was responsible for all corporate governance matters until 2014. Prior to joining Endo in 2000 as Endo’s Senior Vice President, General Counsel and Secretary, she practiced law in the New York office of the law firm Skadden, Arps, Slate, Meagher & Flom LLP, where she specialized in mergers & acquisitions, securities and corporate law. At Endo, she is responsible for all aspects of the company’s legal function, including securities law, litigation, intellectual property and commercial law, as well as overseeing compliance with current laws and existing pharmaceutical company guidelines relating to, among other things, clinical, sales and marketing practices. Ms. Manogue received her J.D. from Fordham Law School and her B.A. cum laude from Middlebury College. She is currently on the Board of Directors for the Association of Corporate Counsel Greater Philadelphia/Delaware Valley Chapter. Ms. Manogue was the 2011-2012 Chairperson of the PhRMA Law Section and was a member of the Board of Trustees of the Healthcare Institute of New Jersey (“HINJ”) from 2010-2014 and a member of HINJ’s Finance and Audit Committee from 2012-2014.
Info Source
News
Short Profile